W. Sawyer

602 total citations
17 papers, 277 citations indexed

About

W. Sawyer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W. Sawyer has authored 17 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W. Sawyer's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Anesthesia and Pain Management (2 papers). W. Sawyer is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Anesthesia and Pain Management (2 papers). W. Sawyer collaborates with scholars based in United Kingdom, United States and Italy. W. Sawyer's co-authors include Adam Lloyd, Andrea Riccardo Filippi, Celeste Lindley, Rafał Dziadziuszko, M.R. García Campelo, Gunnar Lose, J. B. Meade, Niels Klarskov, Jean-Baptiste Paoli and Marina Chiara Garassino and has published in prestigious journals such as Journal of Neurochemistry, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

W. Sawyer

17 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Sawyer United Kingdom 7 122 76 55 50 36 17 277
Jason Chiang Australia 9 82 0.7× 92 1.2× 37 0.7× 52 1.0× 24 0.7× 16 269
Juliette C. Thompson United Kingdom 11 78 0.6× 41 0.5× 66 1.2× 40 0.8× 26 0.7× 18 344
Andrew W. Hitchings United Kingdom 10 45 0.4× 40 0.5× 98 1.8× 23 0.5× 24 0.7× 27 318
Marzyeh Amini Netherlands 7 94 0.8× 132 1.7× 19 0.3× 15 0.3× 13 0.4× 12 246
Shannon Cartier United States 8 89 0.7× 52 0.7× 24 0.4× 29 0.6× 12 0.3× 13 338
Kate Van Brunt United States 11 223 1.8× 24 0.3× 96 1.7× 30 0.6× 59 1.6× 30 415
Emily Peach United Kingdom 9 39 0.3× 37 0.5× 44 0.8× 17 0.3× 14 0.4× 17 241
Matthew J. Klebanoff United States 7 96 0.8× 180 2.4× 23 0.4× 26 0.5× 16 0.4× 14 342
Susannah Sadler United Kingdom 9 25 0.2× 79 1.0× 21 0.4× 25 0.5× 31 0.9× 20 263

Countries citing papers authored by W. Sawyer

Since Specialization
Citations

This map shows the geographic impact of W. Sawyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Sawyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Sawyer more than expected).

Fields of papers citing papers by W. Sawyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Sawyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Sawyer. The network helps show where W. Sawyer may publish in the future.

Co-authorship network of co-authors of W. Sawyer

This figure shows the co-authorship network connecting the top 25 collaborators of W. Sawyer. A scholar is included among the top collaborators of W. Sawyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Sawyer. W. Sawyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shah, Riyaz, Nicolas Girard, Saurabh Nagar, et al.. (2021). European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review. Drugs - Real World Outcomes. 8(4). 537–545. 9 indexed citations
2.
3.
4.
McDonald, Fiona, F. Mornex, Marina Chiara Garassino, et al.. (2021). 79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Journal of Thoracic Oncology. 16(4). S738–S739. 10 indexed citations
5.
Filippi, Andrea Riccardo, et al.. (2021). DUART: Durvalumab After Radiotherapy in Patients with Unresectable, Stage III NSCLC who are Ineligible for Chemotherapy. Future Oncology. 17(34). 4657–4663. 9 indexed citations
6.
Filippi, Andrea Riccardo, et al.. (2021). 95TiP DUART: A phase II study of durvalumab following radiotherapy in patients with unresectable, stage III NSCLC ineligible for chemotherapy. Journal of Thoracic Oncology. 16(4). S747–S747. 3 indexed citations
7.
Garassino, Marina Chiara, Julien Mazières, Martin Reck, et al.. (2021). 78MO Early safety assessment of durvalumab after sCRT in patients with stage III, unresectable NSCLC (PACIFIC-6). Journal of Thoracic Oncology. 16(4). S737–S737. 2 indexed citations
8.
Girard, Nicolas, Rainer Fietkau, Marina Chiara Garassino, et al.. (2020). 1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Annals of Oncology. 31. S805–S806. 2 indexed citations
9.
Kim, YC, Seung Soo Yoo, Keith L. Davis, et al.. (2020). 413P South Korean real-world treatment patterns in patients with EGFRm NSCLC. Annals of Oncology. 31. S1403–S1403. 1 indexed citations
10.
Banerjee, Susana, Richard Davidson, Kimmie McLaurin, W. Sawyer, & Gráinne H. Long. (2020). Adverse events in women switching from olaparib capsules to tablets: retrospective observational study of US claims data. Future Oncology. 16(11). 643–654. 2 indexed citations
11.
12.
Newgreen, Donald, et al.. (2015). 610 Solifenacin in children and adolescents with over-active bladder: Results of a Phase 3 clinical trial. European Urology Supplements. 14(2). e610–e610a. 1 indexed citations
13.
Sawyer, W., et al.. (2002). Patient-Specific Factors Affecting Patient-Controlled Analgesia Dosing. Journal of Pain & Palliative Care Pharmacotherapy. 16(2). 5–21. 3 indexed citations
14.
Glaholm, J., et al.. (2001). Early results from the UK Head and Neck (UKHAN) Trial: The role of chemotherapy in primary management of advanced head and neck cancer. UCL Discovery (University College London). 1 indexed citations
15.
Lloyd, Adam, et al.. (2001). Impact of Long-Term Complications on Quality of Life in Patients with Type 2 Diabetes not Using Insulin. Value in Health. 4(5). 392–400. 183 indexed citations
16.
17.
Lindley, Celeste, et al.. (1994). Comparison of PT, aPTT, and Factor VII Values Obtained by Concurrent Sample Collection by Direct Venipuncture and Peripheral Venous Catheters. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(2). 224–228. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason Chiang Breakdown of academic impact, for papers by Juliette C. Thompson Breakdown of academic impact, for papers by Andrew W. Hitchings Breakdown of academic impact, for papers by Marzyeh Amini Breakdown of academic impact, for papers by Shannon Cartier Breakdown of academic impact, for papers by Kate Van Brunt Breakdown of academic impact, for papers by Emily Peach Breakdown of academic impact, for papers by Matthew J. Klebanoff Breakdown of academic impact, for papers by Susannah Sadler
Rankless by CCL
2026